Carnosine - an antioxidant for aging and the brain (table)
Karnozyna: tabela, ile, kiedy i jak. Przewodnik u Bucha.
Carnosine (beta-alanyl-L-histidine) is a dipeptide discovered in 1900 by Russian chemist Vladimir Gulevitch - and for over a hundred years it remained in the shadow of more well-known antioxidants. Interest in it increased when researchers discovered that the level of carnosine in skeletal muscles decreases by 63% between the ages of 10 and 70, and its concentration correlates with vitality and cognitive abilities (Stuerenburg and Kunze, Archives of Gerontology and Geriatrics, 1999). Carnosine exhibits several distinct biological mechanisms: pH buffering, scavenging free radicals, chelating heavy metals, and - perhaps most importantly - inhibiting protein glycation. This article provides you with specific data: a dosing table, an overview of mechanisms, and information on what studies really confirm.
KEY INFORMATION
• Carnosine is a natural dipeptide (beta-alanine + histidine) primarily present in muscles and the brain - its level decreases by 63% between the ages of 10 and 70.
• Key property: inhibition of protein glycation - carnosine reacts with reactive carbonyls before they attack proteins and DNA.
• Clinical studies used 500-2000 mg daily; the standard protocol is 500-1000 mg in two doses in the morning and at noon.
• Beta-alanine is a cheaper alternative for athletes - it indirectly raises the level of carnosine in muscles.
• A single RCT study showed improvement in language functions in children with autism at 800 mg/day - replication is required.
What is carnosine and why does it decrease with age?
Carnosine is a dipeptide composed of beta-alanine and L-histidine. The natural concentration in skeletal muscles is 5-10 mmol/kg of dry tissue mass - it is one of the highest concentrations among all endogenous dipeptides. The brain, heart, and kidneys also contain carnosine, although in smaller amounts. In the diet, carnosine mainly comes from meat - vegan and vegetarian diets provide very little.
Why does carnosine decrease with age? The main culprit is the enzyme carnosinase (CN1) - it breaks down carnosine in the blood into beta-alanine and histidine. Carnosinase activity increases with age, accelerating the degradation of carnosine before it reaches the tissues. At the same time, endogenous synthesis decreases. The result is a progressive deficiency in tissues, which translates into weaker pH buffering in muscles, poorer protection of proteins against glycation, and increasing oxidative damage.
Important information for supplementers: orally ingested L-carnosine is quickly broken down by carnosinase in the blood - only a fraction reaches the tissues in unchanged form. Therefore, higher doses are used than would be suggested by tissue content alone. A strategy to bypass this problem is to supplement with beta-alanine - it raises tissue levels of carnosine by providing a substrate for synthesis, bypassing degradation by carnosinase.
Tabela dawkowania karnozyny - ile, kiedy i jak
The table below is based on data from published clinical and observational studies. There are no official regulatory guidelines for carnosine as a supplement - doses are a result of available studies.
| Purpose of use | Starting Dose | Standard dose | Maximum dose | When to take | Notes |
|---|---|---|---|---|---|
| Antioxidant protection / anti-aging | 500 mg | 500-1000 mg | 2000 mg | In the morning and at noon | Not in the evening - it may disrupt sleep. |
| Support for cognitive functions | 500 mg | 500-1000 mg | 1500 mg | In the morning and at noon | Efekty po 4-8 tygodniach |
| Sports / muscle endurance | 400 mg | 800-1200 mg | 2000 mg | Before and after training | Beta-alanine may be more effective for athletes |
| Inhibition of glycation (diabetes, AGE) | 500 mg | 1000 mg | 2000 mg | With meals | Consult a doctor if taking diabetes medication |
| Attention: Divide the daily dose into 2 portions. Avoid taking it in the evening - it may cause mild insomnia. Supplement on an empty stomach or with a light meal - a high-calorie meal may slow absorption. | |||||
Carnosine as a glycation inhibitor - why is it important?
Protein glycation (the non-enzymatic binding of sugars to proteins) leads to the formation of so-called AGEs (advanced glycation end-products). AGEs damage skin collagen (causing stiffness and loss of elasticity), vascular endothelium (increasing the risk of atherosclerosis), the eye lens (contributing to cataracts), and nerve cells. The accumulation of AGEs correlates with the rate of biological aging.
Carnosine inhibits glycation through a mechanism called "carbonyl scavenging" - it reacts with reactive carbonyls (4-hydroxynonenal, acrolein, malondialdehyde) before they bind to proteins or DNA, forming a carnosine-carbonyl complex that is safely excreted. This mechanism is fundamentally different from classical antioxidants that act on reactive oxygen species.
In vitro studies have shown that carnosine can reverse already formed glycation - the so-called "carbonyl-scavenging" effect allows for the restoration of the proper structure of partially glycated proteins (Hipkiss, International Journal of Biochemistry and Cell Biology, 2001). This is an exciting property - most antioxidants only prevent damage, while carnosine can partially reverse it. Caveat: most of these studies are cell or animal experiments - clinical data in humans are limited.
Carnosine and the brain and cognitive functions
The brain is particularly vulnerable to oxidative stress and glycation - it consumes an disproportionately large amount of oxygen relative to its mass (about 20% of total consumption at 2% of body mass) and is rich in lipids that easily undergo peroxidation. Carnosine crosses the blood-brain barrier, although to a limited extent.
Clinical study published in Journal of Child Neurology showed that 800 mg of L-carnosine daily for 8 weeks improved language functions (score on the Peabody Picture Vocabulary test) and behavior in children with autism compared to placebo (Chez et al., 2002). This is one of the most cited clinical studies on carnosine, but the sample was small (31 children) and the results have not been replicated in a large RCT. This is not an approved therapeutic intervention.
In animal model studies, carnosine has shown neuroprotection in models of Alzheimer's disease (inhibiting beta-amyloid aggregation) and Parkinson's disease (protecting dopaminergic neurons from oxidative damage). Clinical studies in humans are in the early stages - more data is needed to draw practical conclusions for these indications.
Carnosine and sports - pH buffering and performance
In muscle tissue, carnosine plays a crucial buffering role: it neutralizes hydrogen ions produced during intense exercise (lactic acid, H+ ions), delaying muscle acidosis and fatigue. This mechanism is well-supported by research - a meta-analysis of 40 clinical studies showed that beta-alanine supplementation (which raises carnosine levels in muscles) improved performance in efforts lasting 1-4 minutes by about 2.85% (Hobson et al., Amino Acids, 2012).
For strength and endurance athletes, beta-alanine (3-6 g daily) may be a better choice than direct L-carnosine - it is cheaper and more effectively raises tissue levels of carnosine in muscles. The only significant side effect of beta-alanine is paresthesia (tingling of the skin) at doses above 2 g at once - mild and transient. This can be avoided by dividing the daily dose into 4-5 smaller portions.
Frequently Asked Questions
How much carnosine should be taken daily?
Clinical studies used 500-2000 mg daily. The standard protocol is 500-1000 mg in two doses in the morning and afternoon. Do not take in the evening - it may cause mild insomnia. Doses above 2000 mg have not been widely studied.
What is carnosine and why does it decrease with age?
Carnosine is a dipeptide (beta-alanine + histidine) naturally present in muscles and the brain. Its level decreases by 63% between the ages of 10 and 70 (Stuerenburg and Kunze, 1999) - mainly due to increased activity of the enzyme carnosinase and reduced synthesis. The result is poorer pH buffering in muscles, weaker protection against glycation, and increasing oxidative stress in tissues.
What is the difference between carnosine and beta-alanine?
Beta-alanine is a component of carnosine - beta-alanine supplementation indirectly raises carnosine levels in muscles and is cheaper. L-carnosine provides a ready-made dipeptide but is quickly broken down in the blood by carnosinase. Beta-alanine is better for muscle effects, while L-carnosine is better for systemic, anti-glycation, and neurological effects.
Does carnosine help with autism?
One small RCT from 2002 showed improvement in language functions and behavior in children with autism at 800 mg/day for 8 weeks (Chez et al., 2002). The results are promising, but the study was small and has not been replicated in a large group. This is not an approved intervention - the decision requires consultation with a neurologist or child psychiatrist.
Is carnosine safe?
Yes - good safety profile at doses up to 2000 mg daily. Mild sleep disturbances have been occasionally reported with evening doses above 1000 mg. No known serious drug interactions. Individuals with kidney diseases should consult their doctor before use.
Carnosine and vision - protection of the lens and retina
Carnosine and its derivative N-acetyl-carnosine have documented protective properties for eye tissues. The eye lens is particularly vulnerable to glycation and oxidative stress - both processes contribute to the formation of cataracts. Carnosine inhibits the glycation of crystallin (the structural protein of the lens), which may slow the progression of lens opacification.
Clinical study published in Drugs in R&D showed that eye drops containing 1% N-acetyl-carnosine used for 6 months improved visual acuity and lens transparency in 90% of patients with senile cataracts compared to placebo (Babizhayev i in., Drugs in R&D, 2002). The results are promising, but the study was small and sponsored by the manufacturer - independent replications are needed. N-acetyl-carnosine in drops is a different product than oral L-carnosine - the local action on the lens is direct, while oral carnosine has limited penetration into eye structures.
The retina also benefits from the antioxidant protection of carnosine - high levels of carnosinase in the serum of older individuals correlate with a higher risk of age-related macular degeneration (AMD) in some observational studies. The protective mechanism: carnosine neutralizes acrolein and 4-hydroxynonenal - lipid aldehydes that are particularly toxic to retinal photoreceptors.
Carnosine and chelation of heavy metals
One of the lesser-known properties of carnosine is its ability to chelate heavy and transition metal ions - especially copper (Cu²⁺), zinc (Zn²⁺), and iron (Fe²⁺/Fe³⁺). Uncontrolled ions of these metals catalyze Fenton reactions generating highly reactive hydroxyl radicals (OH•) - the most toxic form of reactive oxygen species.
In the brain, free copper and zinc ions are particularly problematic - their accumulation in amyloid plaques in Alzheimer's disease is well documented. Carnosine chelates these ions, reducing their reactivity. In vitro studies have shown that carnosine inhibits beta-amyloid aggregation induced by copper and zinc ions. This is one of the mechanisms through which carnosine may protect neurons from damage related to neurodegeneration - although clinical evidence in humans is in the early stages.
Practical implication: individuals exposed to heavy metal exposure (industrial workers, residents of polluted areas), as well as those with genetically elevated risk of Alzheimer's disease may consider carnosine supplementation as part of a multi-faceted neurological protection strategy - always in consultation with a physician.
This article is for informational and educational purposes and does not replace consultation with a doctor. If you are pregnant, breastfeeding, taking medications, or have chronic conditions, consult the use of supplements or herbs with a specialist.
Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04
